- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Gamma-Aminobutyric Acid (GABA) Receptor market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.9% during the forecast period.
This report presents the market size and development trends by detailing the Gamma-Aminobutyric Acid (GABA) Receptor market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gamma-Aminobutyric Acid (GABA) Receptor market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gamma-Aminobutyric Acid (GABA) Receptor industry and will help you to build a panoramic view of the industrial development.
Gamma-Aminobutyric Acid (GABA) Receptor Market, By Type:
GABAA
GABAB
Gamma-Aminobutyric Acid (GABA) Receptor Market, By Application:
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
Other
Some of the leading players are as follows:
Osmotica Pharmaceutical
Athena Drug Delivery Solutions
VIVUS
sanofi-aventis
Advicenne
H.LundBeck
AstraZeneca
Biocodex
Novartis
Eli Lilly & Company
Elan Corporation
XenoPort
GlaxoSmithKline
Pfizer
NovaDel Pharma
OVATION Pharmaceuticals
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Gamma-Aminobutyric Acid (GABA) Receptor Market: Technology Type Analysis
-
4.1 Gamma-Aminobutyric Acid (GABA) Receptor Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Gamma-Aminobutyric Acid (GABA) Receptor Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 GABAA
4.3.2 GABAB
5 Gamma-Aminobutyric Acid (GABA) Receptor Market: Product Analysis
-
5.1 Gamma-Aminobutyric Acid (GABA) Receptor Product Market Share Analysis, 2018 & 2026
-
5.2 Gamma-Aminobutyric Acid (GABA) Receptor Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Gamma-Aminobutyric Acid (GABA) Receptor Market: Application Analysis
-
6.1 Gamma-Aminobutyric Acid (GABA) Receptor Application Market Share Analysis, 2018 & 2026
-
6.2 Gamma-Aminobutyric Acid (GABA) Receptor Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Attention Deficit Hyperactivity Disorder
6.3.2 Psychiatric Disorders
6.3.3 Alzheimer's Disease
6.3.4 Chronic Obstructive Pulmonary Disease
6.3.5 Memory Impairment
6.3.6 Other
7 Gamma-Aminobutyric Acid (GABA) Receptor Market: Regional Analysis
-
7.1 Gamma-Aminobutyric Acid (GABA) Receptor Regional Market Share Analysis, 2018 & 2026
-
7.2 Gamma-Aminobutyric Acid (GABA) Receptor Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Osmotica Pharmaceutical
9.1.1 Osmotica Pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Athena Drug Delivery Solutions
9.2.1 Athena Drug Delivery Solutions Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 VIVUS
9.3.1 VIVUS Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 sanofi-aventis
9.4.1 sanofi-aventis Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Advicenne
9.5.1 Advicenne Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 H.LundBeck
9.6.1 H.LundBeck Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 AstraZeneca
9.7.1 AstraZeneca Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Biocodex
9.8.1 Biocodex Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Novartis
9.9.1 Novartis Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Eli Lilly & Company
9.10.1 Eli Lilly & Company Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Elan Corporation
9.11.1 Elan Corporation Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 XenoPort
9.12.1 XenoPort Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 GlaxoSmithKline
9.13.1 GlaxoSmithKline Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Pfizer
9.14.1 Pfizer Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 NovaDel Pharma
9.15.1 NovaDel Pharma Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 OVATION Pharmaceuticals
9.16.1 OVATION Pharmaceuticals Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
The List of Tables and Figures (Totals 75 Figures and 144 Tables)
Figure GABAA Gamma-Aminobutyric Acid (GABA) Receptor market, 2015 - 2026 (USD Million)
Figure GABAB Gamma-Aminobutyric Acid (GABA) Receptor market, 2015 - 2026 (USD Million)
Figure Attention Deficit Hyperactivity Disorder market, 2015 - 2026 (USD Million)
Figure Psychiatric Disorders market, 2015 - 2026 (USD Million)
Figure Alzheimer's Disease market, 2015 - 2026 (USD Million)
Figure Chronic Obstructive Pulmonary Disease market, 2015 - 2026 (USD Million)
Figure Memory Impairment market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Gamma-Aminobutyric Acid (GABA) Receptor market, by country, 2015 - 2026 (USD Million)
-
Table North America Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table North America Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table North America Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Canada Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Canada Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Europe Gamma-Aminobutyric Acid (GABA) Receptor market, by country, 2015 - 2026 (USD Million)
-
Table Europe Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Europe Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Europe Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Germany Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Germany Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table France Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table France Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Italy Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Italy Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Spain Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Spain Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table China Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table China Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Japan Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Japan Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table India Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table India Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Gamma-Aminobutyric Acid (GABA) Receptor market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table MEA Gamma-Aminobutyric Acid (GABA) Receptor market, by country, 2015 - 2026 (USD Million)
-
Table MEA Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table MEA Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table MEA Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Gamma-Aminobutyric Acid (GABA) Receptor market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Gamma-Aminobutyric Acid (GABA) Receptor market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Gamma-Aminobutyric Acid (GABA) Receptor market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Osmotica Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Athena Drug Delivery Solutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table VIVUS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table sanofi-aventis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advicenne Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table H.LundBeck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biocodex Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly & Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Elan Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table XenoPort Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NovaDel Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table OVATION Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-